Santa Cruz Biotechnology offers a broad range of NR2E3 monoclonal antibodies for research focused on understanding NR2E3 protein function. The monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NR2E3, also known as the nuclear receptor subfamily 2 group E member 3, plays a critical role in the regulation of gene expression during retinal development and is essential for photoreceptor cell differentiation. The function of NR2E3 is vital for maintaining the integrity of the visual system, and mutations in the NR2E3 gene have been linked to various retinal diseases. Understanding NR2E3 mechanisms can provide insights into potential therapeutic targets for vision-related disorders. Researchers can utilize NR2E3 monoclonal antibodies to explore protein expression patterns in different cell types and tissues. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of NR2E3 localization and interactions. Investigating NR2E3 expression and regulation contributes valuable insights to vision science and retinal development research. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of retinal development and disease mechanisms.